首页> 中文期刊> 《介入放射学杂志》 >经导管肺动脉化疗栓塞术介入治疗不能切除的转移性肺癌

经导管肺动脉化疗栓塞术介入治疗不能切除的转移性肺癌

         

摘要

Transarterial chemoembolization (TACE) has been recommended as a first-line therapy for patients with unresectable hepatocellular carcinomas. Similarly, this type of treatment for lung tumors, transpulmonary chemoembolization (TPCE), has also been regarded as a novel approach for unresectable pulmonary metastases. This article aims to make a comprehensive review about the history of TPCE, the blood supply of the metastatic pulmonary tumors, the indications and contraindications of this technique, the operative procedures, the complications and limitations, etc.(J Intervent Radiol, 2012, 21: 344-347)%经导管动脉化疗栓塞术已经被认为是手术不能切除肝癌的一线治疗方法.然而,此技术也被认为是不能手术切除转移性肺癌新的治疗方法.本文对该技术的历史、转移性肺癌的血供、适应证、禁忌证、操作步骤、并发症、疗效和局限性等进行综述.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号